388 results on '"Sathekge M"'
Search Results
2. Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer
3. Letter from the Editors
4. Letter From the Editors
5. Considering the Costs of Targeted Radionuclide Therapies in Prostate Cancer
6. Theranostics in breast cancer.
7. Emerging theragnostic radionuclide applications for hepatocellular carcinoma.
8. Letter From the Editors
9. Emerging theragnostic radionuclide applications for hepatocellular carcinoma
10. COVID-19 pandemic: guidance for nuclear medicine departments
11. Comparison of DOTA and NODAGA as chelates for 68Ga-labelled CDP1 as novel infection PET imaging agents
12. Theranostics in breast cancer
13. Letter From the Editors
14. Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: how important is internal dosimetry?
15. Letter from the Editors
16. Correction to: Nuclear medicine services after COVID-19: gearing up back to normality
17. Letter from the Editors
18. Letter From the Editors
19. Letter from the Editors
20. Letter from the Editors
21. Letter from the Editors
22. 1789P Low- and high-volume disease in mHSPC: From CHAARTED to PSMA PET
23. Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.
24. Letter from the Editors
25. Correlation between serum calcium levels and dual-phase 99mTc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism
26. Nuclear medicine services after COVID-19: gearing up back to normality
27. The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial
28. Letter from the Editors
29. The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours
30. Letter from the Editors
31. Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect
32. Work-based assessment: A critical element of specialist medical training
33. Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
34. South African guidelines for receptor radioligand therapy (RLT) with Lu-177-PSMA in prostate cancer.
35. Comparison of DOTA and NODAGA as chelates for 68Ga-labelled CDP1 as novel infection PET imaging agents.
36. Prof. Alpheus Mabose Segone
37. Principal component analysis of texture features derived from FDG PET images of melanoma lesions
38. Work-based assessment: A critical element of specialist medical training
39. The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.
40. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence
41. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers
42. The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours.
43. Ensuring effective and sustainable radionuclide delivery and its impact on the development of nuclear medicine in the developing world with special reference to Nigeria
44. Blood-brain barrier integrity in a zolpidem-responder patient
45. Imaging of Pulmonary Tuberculosis with 18F-Fluoro-Deoxy-Glucose and 18F-Ethylcholine
46. Pheochromocytomas/Paragangliomas and two cases
47. Development and Prospects of Dedicated Tracers for the Molecular Imaging of Bacterial Infections
48. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers
49. Appropriate in dications for positron emission to mography/computed tomography, 2015.
50. Appropriate indications for positron emission tomography/computed tomography, 2015.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.